Berry Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$222K Hold
3,581
0.1% 107
2020
Q3
$216K Hold
3,581
0.12% 106
2020
Q2
$211K Hold
3,581
0.13% 98
2020
Q1
$200K Sell
3,581
-6,464
-64% -$395K 0.15% 94
2019
Q4
$645K Buy
+10,045
New +$575K 0.35% 56

Other funds holding BMY

Berry Group's BMY Position: Q4 2020 in Review

Berry Group held its Bristol-Myers Squibb (BMY) position steady in Q4 2020 at 3,581 shares worth $222K. The position accounts for 0.1% of the portfolio, ranked #107.

Berry Group first reported a position in BMY in Q4 2019 and has held it in 5 quarters since. The position peaked at $645K in Q4 2019. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Berry Group held 3,581 shares of Bristol-Myers Squibb worth $222K as of Q4 2020.
  • Berry Group left its Bristol-Myers Squibb share count unchanged in Q4 2020.
  • Bristol-Myers Squibb made up 0.1% of Berry Group's portfolio in Q4 2020, its #107 holding.
  • Berry Group first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 5 quarters since.
  • Berry Group's Bristol-Myers Squibb position peaked at $645K in Q4 2019.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Berry Group's 13F filing for Q4 2020, filed 11 Feb 2021.